 |
 |
"Memorial Sloan Kettering Cancer Center 1275 York Ave. Unfledged York, NY 10021 Common States" Looks like they used some kind of translation program, maybe? Kathleen 2009/7/22 Nic Marais <[log in to unmask]> > OMG! > > "The late study shows that therapeutic cloning can take up Parkinson's > disease in a mouse follow." > > "While this current business is in animals, it could have future > implications as this method may be an effective habit to reduce transplant > rejection and heighten recapture in other diseases and in other organ > systems." > > (To quote only some of numerous examples;-) > > But who cares about the Japenglish of their reports. As long as they carry > on with the good work! > > Nic 57/15 > > > On Wed, Jul 22, 2009 at 7:12 AM, rayilynlee <[log in to unmask]> wrote: > > > Therapeutic Cloning Treats Parkinson's Disease In Mice > > July 20, 2009 > > Research led by investigators at Statue Sloan-Kettering Cancer Center > > (MSKCC) has shown that salutary cloning, also known as somatic-cell > nuclear > > transfer (SCNT), can be used to expound on Parkinson's disease in mice. > The > > study's results are published in the Procession 23 online number of the > > minutes Nature Drug. > > > > For the principal term, researchers showed that health-giving cloning or > > SCNT has been successfully used to study disease in the selfsame subjects > > from whom the endorse cells were derived. While this current business is > in > > animals, it could have future implications as this method may be an > > effective habit to reduce transplant rejection and heighten recapture in > > other diseases and in other organ systems. > > > > In therapeutic cloning or SCNT, the focus of a somatic cell from a donor > > subject is inserted into an egg from which the heart has been removed. > This > > cell then develops into a blastocyst from which embryonic stem cells can > be > > harvested and differentiated for corrective purposes. As the genetic dirt > in > > the resulting staunch cells comes from the donor subject, healthy cloning > or > > SCNT would yield obedient to-unique to cells that are spared by the > > invulnerable system after transplantation. > > > > The late study shows that therapeutic cloning can take up Parkinson's > > disease in a mouse follow. The scientists used skin cells from the tail > of > > the creature to fashion customized or autologous dopamine neurons the > > missing neurons in Parkinson's disease. The mice that received neurons > > derived from one at a time matched stem cell lines exhibited neurological > > recovery. But when these neurons were grafted into mice that did not > > genetically match the transplanted cells, the cells did not survive well > and > > the mice did not recover. > > > > The work was led by higher- ranking author Lorenz Studer, MD, Head of the > > Shoot Stall and Tumor Biology Laboratory within the Sloan-Kettering Begin > at > > MSKCC, and get up to author Viviane Tabar, MD, Neurosurgeon and control > room > > scientist at MSKCC. The work was performed in collaboration with > scientists > > at the Riken Alliance in Kobe, Japan. > > > > Other MSKCC researchers who contributed to this study are: Mark > Tomishima, > > Georgia Panagiotakos, George Al-Shamy, Bill Chan, and Jayanthi Menon. > > Scientists in Japan include group leader Teruhiko Wakayama and scientists > > Eiji Mizutani, Sayaka Wakayama and Hiroshi Ohta. This research was > supported > > by the US National Institute of Neurological Disorders and Strike, the > Starr > > Tri-institutional Stem Chamber Initiative, the Michael J. Fox Foundation > > seeking Parkinson's Research, the Michael W. McCarthy Fundamental > principle > > and an unrestricted grant from the Kinetics Understructure. > > > > Memorial Sloan Kettering Cancer Center > > 1275 York Ave. > > Unfledged York, NY 10021 > > Common States > > http://www.mskcc.org > > > > Rayilyn Brown > > Director AZNPF > > Arizona Chapter National Parkinson Foundation > > [log in to unmask] > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > > [log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn